Showing results (1561-1570 of 2,320) with videos related to
Sort By:
Pageof 232
Expert Opinion on Therapeutic Targets|August 21, 2013
Targeting the 'Janus face' of the B2-bradykinin receptorNelly Blaes, Jean-Pierre GirolamiExpert Opinion on Therapeutic Targets|August 24, 2013
Contributions of HIV-1 Nef to immune dysregulation in HIV-infected patients: a therapeutic target?Wojciech Witkowski, Bruno VerhasseltExpert Opinion on Therapeutic Targets|August 13, 2013
The DNA helicase-primase complex as a target for herpes viral infectionSandra K Weller, Robert D KuchtaExpert Opinion on Therapeutic Targets|August 15, 2013
Targeting protein-bound uremic toxins in chronic kidney diseaseToshimitsu NiwaExpert Opinion on Therapeutic Targets|September 24, 2013
MicroRNAs and multiple sclerosis: from physiopathology toward therapyAmeneh Zare-Shahabadi, Yves Renaudineau, Nima RezaeiExpert Opinion on Therapeutic Targets|January 7, 2016
The role of Sema4D/CD100 as a therapeutic target for tumor microenvironments and for autoimmune, neuroimmune and bone diseasesMingfu Wu, Jing Li, Qinglei Gao, et al.Expert Opinion on Therapeutic Targets|September 12, 2015
The potential of Beclin 1 as a therapeutic target for the treatment of breast cancerYoon Yang Jung, Yu Kyung Lee, Ja Seung KooExpert Opinion on Therapeutic Targets|January 23, 2016
Targeting epigenetic regulators for cancer therapy: modulation of bromodomain proteins, methyltransferases, demethylases, and microRNAsKathy A Gelato, David Adler, Matthias Ocker, et al.Expert Opinion on Therapeutic Targets|January 27, 2016
On the horizon: trophic peptide growth factors as therapy for neonatal short bowel syndromeDavid W Lim, Paul W Wales, Justine M Turner, et al.Expert Opinion on Therapeutic Targets|February 6, 2016
Lysyl Oxidase Isoforms and Potential Therapeutic Opportunities for Fibrosis and CancerPhilip C TrackmanPageof 232